17,400 Shares in Incyte Corporation $INCY Acquired by New England Research & Management Inc.
New England Research & Management Inc. bought a new stake in Incyte Corporation (NASDAQ:INCY – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 17,400 shares of the biopharmaceutical company’s stock, valued at approximately $1,719,000. Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. […]
22 Mar 10:10 · The Markets Daily